Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...
RIO GRANDE, Puerto Rico (AP) — Karl Vilips of Australia ran off three straight birdies to break out of an unexpected duel and played his best golf down the stretch Sunday for an 8-under 64 to ...
Lilly Meister lost her starting job, initially planning to step into Mackenzie Holmes' starting spot, but still played routine minutes. Her confidence has to be at an all-time high after a "spot ...
Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects
Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors.
Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...
Also on Friday, Wang Wentao, the Chinese commerce minister, met David Ricks, chief executive officer of the pharmaceutical company Eli Lilly and Co., and told the American executive that Beijing hopes ...
Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...
American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...
J&J rival Eli Lilly and Co. announced in late February that it planned to build four new factories in the U.S. Both Lilly and J&J cited tax cut legislation passed in 2017 as factors in their U.S ...
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...
India has taken a major step in the fight against obesity and diabetes with the launch of Mounjaro, a groundbreaking drug from American pharmaceutical giant Eli Lilly and Co. The company announced ...
Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose vials, with pricing set at Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results